ÂÜÀòÂÒÂ×

Mary Fridman is a seasoned medical professional with extensive experience in oncology and nursing education. Currently serving as a Senior Medical Science Liaison at MacroGenics, Inc. since March 2021, Mary previously held the position of Director of Medical Science Liaison at UroGen Pharma from April 2019 to March 2021, and was a Medical Science Liaison at Genentech from 2009 to 2019. Additional roles include Adjunct Instructor for a Graduate Research Course at the City University of New York-Hunter Bellevue School of Nursing (2013-2015) and Clinical Oncology Specialist at Amgen (2003-2009). Mary also worked as a Nurse Practitioner/Research Manager at NYU Clinical Cancer Center, focusing on gastrointestinal oncology clinical trials. Mary's educational background includes a Nursing Research Doctorate from the City University of New York-Graduate Center, a Nurse Practitioner Certificate from New York University, a Master's degree in Nursing Education, and a Bachelor of Science in Nursing from Hunter-Bellevue School of Nursing.